| epidemiology of candidemia at a children's hospital, 2002 to 2006. | there are few recent studies evaluating trends in the epidemiology of candidemia including changes in species or utilization of antifungal agents in children. | 2009 | 19636286 |
| prospective evaluation of candida species colonization in hospitalized cancer patients: impact on short-term survival in recipients of marrow transplantation and patients with hematological malignancies. | most hematogenous candidiasis originates from endogenous host flora. the impact of clinically prominent candida colonization on short-term mortality (<or=14 weeks) was prospectively studied in 193 hospitalized patients from 1998 to 1999. clinically prominent colonization included yeasts isolated from all sterile body sites and >50 colonies of candida from non-sterile sites. fourteen (7.1%) patients were granulocytopenic (anc <or=100/microl). nineteen (9.8%) had undergone marrow transplantation, ... | 2002 | 12476287 |
| prospective, multicenter surveillance study of candida glabrata: fluconazole and itraconazole susceptibility profiles in bloodstream, invasive, and colonizing strains and differences between isolates from three urban teaching hospitals in new york city (candida susceptibility trends study, 1998 to 1999). | since the 1990s, the substantial increase in the rate of candida glabrata infections has become a serious problem. as most c. glabrata infections arise from the host's endogenous microflora, the present prospective, multicenter analysis included all clinical isolates associated with colonization and with systemic and hematogenous candidiasis. among 347 c. glabrata isolates, the overall rates of resistance to fluconazole (mic > or = 64 micro g/ml) and itraconazole (mic > or = 1 micro g/ml) were 1 ... | 2002 | 12234857 |
| evaluation of mycology laboratory proficiency testing. | changes over the last decade in overt proficiency testing (opt) regulations have been ostensibly directed at improving laboratory performance on patient samples. however, the overt (unblinded) format of the tests and regulatory penalties associated with incorrect values allow and encourage laboratorians to take extra precautions with opt analytes. as a result opt may measure optimal laboratory performance instead of the intended target of typical performance attained during routine patient testi ... | 1999 | 10364601 |